Astrazeneca AZN
NYSE AZN
$186.58 -0.24 (-0.13%)
At close: Nov 6, 2026 · 4:00 PM EST

Astrazeneca (AZN) Sale and Maturity of Investments (2012 - 2024)

Updated

Astrazeneca's Sale and Maturity of Investments - Total was $13 million in FY2024.

Analysis

Astrazeneca (AZN) Sale and Maturity of Investments (2012 - 2024) Analysis & Trends

  • Sale and Maturity of Investments - Total shows a three-year compound annual growth rate of -74.4% (FY2021 to FY2024).
  • The FY2024 figure marks the highest annual Sale and Maturity of Investments - Total since FY2021.
  • Per Business Quant data, Sale and Maturity of Investments - Total in earlier years was $776 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 308.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 315.51 Bn 288.75 Bn - 88.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 2.53 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn 4.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 5.00 Mn
Mar 31, 2024 8.00 Mn
Mar 31, 2021 776.00 Mn
Dec 31, 2015 -447.00 Mn
Dec 31, 2012 -61.00 Mn
API Access

Astrazeneca Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=AZN&period=max&api_key=YOUR_API_KEY